MicroRNAs contribute to the leukemogenic effect of MLL-AF9

被引:0
|
作者
Fleischmann, K. K. [1 ]
von Frowein, J. [1 ]
Magg, T. [1 ]
Pagel, P. [2 ]
Albert, M. [1 ]
Schmid, I [1 ]
Roscher, A. A. [1 ]
机构
[1] Univ Munich, Dr Von Haunerschen Kinderspital, Forschungszentrum Kubus, D-80337 Munich, Germany
[2] Tech Univ Munich, Lehrstuhl Genomorientierte Bioinformat, Wissensch Zentrum, D-8050 Freising Weihenstephan, Germany
来源
KLINISCHE PADIATRIE | 2009年 / 221卷 / 03期
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
14
引用
收藏
页码:197 / 197
页数:1
相关论文
共 50 条
  • [21] An Insertional Mutagenesis Screen for Genes That Cooperate with Mll-AF9 in Leukemogenesis
    Bergerson, Rachel Joy
    Collier, Lara S.
    Lugthart, Sanne
    Allaei, Raha
    Nixon, Molly J.
    Silverstein, Kevin A. T.
    Sarver, Aaron
    Fan, Danhua Flora
    Lamblin, Anne-Francoise J.
    Wolff, Linda
    Kersey, John H.
    O'Sullivan, Gerard
    Delwel, Ruud
    Kogan, Scott C.
    Adams, David J.
    Largaespada, David
    BLOOD, 2009, 114 (22) : 1523 - 1524
  • [22] New Therapeutic Targets For MLL plus AML Identified via Mll-AF9 Depletion
    Fleischmann, K. K.
    Pagel, P.
    Schmid, I.
    Roscher, A. A.
    ANNALS OF HEMATOLOGY, 2015, 94 : S86 - S86
  • [23] Role of AF4 and Dot1 in MLL-AF9 mediated leukemogenesis
    Lumba, Bhavna
    Hemenway, Charles S.
    CANCER RESEARCH, 2011, 71
  • [24] The leukemogenic fusion gene MLL-AF9 alters microRNA expression pattern and inhibits monoblastic differentiation via miR-511 repression
    Katrin K. Fleischmann
    Philipp Pagel
    Julia von Frowein
    Thomas Magg
    Adelbert A. Roscher
    Irene Schmid
    Journal of Experimental & Clinical Cancer Research, 35
  • [25] The leukemogenic fusion gene MLL-AF9 alters microRNA expression pattern and inhibits monoblastic differentiation via miR-511 repression
    Fleischmann, Katrin K.
    Pagel, Philipp
    von Frowein, Julia
    Magg, Thomas
    Roscher, Adelbert A.
    Schmid, Irene
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
  • [26] Conditional Deletion of the Hoxa Cluster in MLL-AF9 Is Incompatible with Leukemia Maintenance
    Kettyle, Laura M.
    Grishagin, Ivan
    Dickson, Glenda J.
    Lebert-Ghali, Charles-Etienne
    Bijl, Janetta Jacoba
    McMullin, Mary Frances
    Lappin, Terence R. J.
    Mills, Ken I.
    Thompson, Alexander
    BLOOD, 2015, 126 (23)
  • [27] Cellular and Molecular Targets of MLL-AF9 in a Novel Conditional Mouse Model
    Stavropoulou, Vaia
    Kaspar, Susanne
    Brault, Laurent
    Juge, Sabine
    Morettini, Stefano
    Tzankov, Alexander
    Kyba, Michael
    Peters, Antoine H. F. M.
    Schwaller, Juerg
    BLOOD, 2012, 120 (21)
  • [28] Reprogramming of MLL-AF9 Leukemic Cells Into Pluripotent Stem Cells in Mice
    Liu, Yanfeng
    Cheng, Hui
    Hu, Linping
    Xu, Jing
    Yuan, Weiping
    Gao, Shaorong
    Cheng, Tao
    BLOOD, 2012, 120 (21)
  • [29] Structure of the MLL CXXC domain–DNA complex and its functional role in MLL-AF9 leukemia
    Tomasz Cierpicki
    Laurie E Risner
    Jolanta Grembecka
    Stephen M Lukasik
    Relja Popovic
    Monika Omonkowska
    David D Shultis
    Nancy J Zeleznik-Le
    John H Bushweller
    Nature Structural & Molecular Biology, 2010, 17 : 62 - 68
  • [30] Desuppressed Expressions of MiR-29 targetsdisturb the Leukemeugenesis of MLL-AF9
    Hu, Wenhuo
    Park, Christopher Y.
    BLOOD, 2015, 126 (23)